chrisvoncsefalvay/vaers-outcomes huggingface dataset:
left arm pain, right arm pain, toe pain, 3 fingers on right hand pain and pains so severe  started March 7th went to Urgent care March 8th then called march 11th and 12th and 13th and was seen again because of more severe pains on April 15th and then it got bad again after the steriods did nothing and went in for blood work on May 3rd Treatments have been steriods, and muscle relaxer and prescription ibprophen  None of that worked
The patient received a Covid vaccine on 1/17/2021  and a couple of days later she developed shingles.
Dizziness, difficultly with balance, lightheaded (contacted the Dr and she suggested fluids and rest) arm and lymph nodes swelled and become very hot difficulty lifting arm and painful.
Mom called stated pt had raised red whelps started all over body AM 10MAR92; pt extremities were swollen, blue; Pt taken to ER & given DPH; t102 (ear); MD felt poss virus;
Fever of 103 evening of 03/19/21. The following day fever remained 100.6 to 101.4
got very sick; Initial information was received on 09-Oct-2020 regarding an unsolicited valid non-serious case from a consumer or non-health care professional via social media.  This case involves a patient (age and gender unspecified) who experienced got very sick (illness), after patient received INFLUENZA VACCINE.  Medical history, medical treatment, vaccination, family history and concomitant medication were not reported.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer) [lot number, expiry date and other dosing details were not reported] for prophylactic vaccination.  On an unknown date, patient developed a non-serious got very sick (illness), (unknown latency) following the administration of INFLUENZA VACCINE.  It was reported by reporter that, "this post I do not believe".   Details of laboratory data not reported.   It was not reported if the patient received any corrective treatment.  At the time of reporting, event outcome was not reported for illness.  There will be no information available on the batch number for this case.
This spontaneous report was received from a physician refers to 25 unspecified patients of unknown demographics. On an unknown date the patient was vaccinated with VARIVAX (Merck) (dosing regimen unspecified). No concomitant medications reported. On an unknown date the medical assistant reported that 25 unspecified patients received a dose of VARIVAX (Merck) that was stored improperly. No adverse effects reported. The outcome of the medication error: unspecified patient received a dose of VARIVAX (Merck) that was used improperly and no adverse effects reported is unknown. Additional information has been requested.
This spontaneous report as received from a licensed practice nurse refers to multiple unspecified patients of unknown age and gender. The patient's concurrent condition, medical history and concomitant medications were not reported. On unknown dates, the patients were administered improperly stored PROQUAD (Merck) lot # L014401, expiry date 23-OCT-2016, lot # L033698, expiry date 28-FEB-2017, lot # L034933, expiry date 11-MAR-2017 (dose number, route and site of administration were not reported). No adverse effects were reported. Temperature excursion was reported as -12 C for 9 hours. Product quality complaint was not involved. This is one of two cases from the same reporter. Additional information has been requested.
bad hangover headache; sleep for 4 hours; chills within 40 minutes of shot; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (sleep for 4 hours), CHILLS (chills within 40 minutes of shot), FATIGUE (fatigue) and HEADACHE (bad hangover headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included HYDROXYCHLOROQUINE SULFATE (PLAQUENIL [HYDROXYCHLOROQUINE SULFATE]), GABAPENTIN, VILAZODONE HYDROCHLORIDE (VIIBRYD) and VITAMINS NOS for an unknown indication.   On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Mar-2021, the patient experienced INSOMNIA (sleep for 4 hours), CHILLS (chills within 40 minutes of shot) and FATIGUE (fatigue). On 19-Mar-2021, the patient experienced HEADACHE (bad hangover headache). The patient was treated with PARACETAMOL (TYLENOL) for Headache, at a dose of 1 dosage form. On 19-Mar-2021, INSOMNIA (sleep for 4 hours), CHILLS (chills within 40 minutes of shot), FATIGUE (fatigue) and HEADACHE (bad hangover headache) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient stated that he had a lot of energy 2 days afterwards. Action taken with mRNA-1273 in response to the events was not applicable.   This case was linked toMOD-2021-079292 (E2B Linked Report).
Memory care resident complaints of feeling "woozy". After much questioning, it was determined that she was dizzy. This occurred an hour after administration of vaccination and continues. Appetite has been good. Refuses to lie down. Denies headache, body aches, nausea,  stiffness, visual disturbance, or injection site pain.  Monitoring vital signs for the next 24 hours; every 2 hours while awake and once during the night per instruction of County Public Health Nurse.
Developed aches, chills, low grade fever (tMAX 99.9) during the night after receiving 2nd Moderna Covid-19 vaccine at 4pm.  Within 36 hr post vaccine, I developed cutaneous rash near injection site on Rt arm measuring 5cm x 3cm.  I previously reported similar cutaneous rash on Lt arm that developed at that injection site measuring 7 cm x 3 cm 9 days after 1st Moderna vaccine.  Rash on Lt arm lasted about 1 week.
my second shot I got fairly sick; with the second shot my lymph nodes have swollen in my armpit to the point I feel like they are too warm under my armpits.; with the second shot my lymph nodes have swollen in my armpit to the point I feel like they are too warm under my armpits.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose:1; Manufacturer unknown), for Covid-19 immunization. The following information was reported: ILLNESS (non-serious), outcome "unknown", described as "my second shot I got fairly sick"; LYMPHADENOPATHY (non-serious), FEELING HOT (non-serious), outcome "unknown" and all described as "with the second shot my lymph nodes have swollen in my armpit to the point I feel like they are too warm under my armpits.".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient experienced an itchy, whole body, red, raised rash 2 to 3 days after getting the first dose of SHINGRIX. The patient did not self-treat the reaction with anything. The patient then received the second SHINGRIX vaccination approximately 3 months after the first vaccine, and there is no reaction noted to the second vaccine. Skin rash, rash and urticaria pruritus.
DTAP-IPV, MMRV,HEP A CLIENT RECIEVED VACCINES.  NO PROBLEMS NOTED AT TIME.  CLIENT AND MOTHER WALKED FROM IMMUNIZATION ROOM TO ADMIN. ROOM FOR MOTHER TO PAY FOR VACCINES.  ABOUT 10 MINUTES AFTER VACCINES, CLIENT BENT OVER TO PICK UP SOMETHING FOR HER MOTHER OFF FLOOR.  A THUMP WAS HEARD AND MOTHER PICKED UP CHILD/CLIENT.  WAS  UNRESPONSIVE FOR LESS THAN 1 (ONE) MINUTE.  SAT IN MOTHERS LAP  AND WAS GIVEN A COOL PAPERTOWEL FOR FACE AND GIVEN A BOTTLE OF WATER.  CLIENT AND MOTHER SAT IN ADMIN ROOM FOR OVER 20 MINUTES. CLIENT WAS RESPONSIVE AND COMMUNICATING AT THE TIME OF DEPARTURE.
Initial report received from a pharmacist on 15 Jan 2010: This patient was vaccinated with S-OIV FLUVIRIN of an unknown batch number, 0.25 ml on 14 Jan 2010 for an inadvertent administration.
Headache, Fever, SWOLLEN ARM, MALAISE Narrative:  Other Relevant History:
The night of the vaccine (4/7/21), she started to feeel disoriented.  The next day, she was disoriented and dizzy.  She felt nausea, extreme abdominal pain and vomited for 2 additional days.  She felt completely better on 4/11/21
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a male patient of unknown age. Information regarding medical history, concurrent conditions and concomitant medications was not provided. During 2014, the patient was inoculated with ZOSTAVAX by a physician for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended but rather caused the patient to contract a persistent strain of herpes zoster. During 2016, the patient was treated by the same physician for a blistering vesicular outbreak and decreased immune symptoms which was then diagnosed as herpes zoster, or shingles. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages.  The outcomes of the events were unknown at the time of reporting. Causality assessment was related. Additional information has been requested.
shingles; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a patient (pt) of unspecified age and unknown gender. Information about concurrent condition, concomitant medication or medical history was not provided. In 2018 the pt was vaccinated with zoster vaccine live(ZOSTAVAX) (strength, dose, route, lot # and expiration date were not reported) as prescribed and/or administered by a pharmacist for the long term prevention of shingles and/or zoster-related conditions. At the time of pt's vaccination, pt relied on the warning label affixed to zoster vaccine live(ZOSTAVAX), and the information relayed through healthcare provider(s) that zoster vaccine live(ZOSTAVAX) was effective in preventing shingles on a permanent basis and did not carry any significant risk of adverse effects, which induced the pt to be vaccinated.  On an unspecified date (reported as subsequent to inoculation), the pt was treated by a physician for shingles. As a direct and proximate result of pt's use of the zoster vaccine live(ZOSTAVAX) vaccine, pt has and will continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future. The outcome of shingles was considered as not recovered. The causality was assessed as related by the lawyer and patient.
Pt feels unwell, achy, fever 103.0 F. Right arm is red, warm, swollen and tender. (R) arm shows 10x10 cm area that is erythematous, w/ swelling. Warmth and tenderness. To lateral aspect.
Experienced immediate pain. Diffuse redness with a lump. Swelling & pain. (Couldn't sleep on that arm). Took TYLENOL.
Light-headedness began 30 minutes after injection. Immediately following the light-headedness, face began to feel numb. Numbness was predominant on facial cheeks. Was similar to the feeling of novocaine wearing off. Numbness lasted for approximately 3 hours and then went away.
Chest pain/tightness, fatigue, lightheadedness, heart palpitations - started Monday, especially with walking briskly or stairs but also when at rest. Slightly better on Tuesday but worse again on Wednesday. Seeked medical care and told likely related to vaccine. Continue to monitor and have been taking ibuprofen and not engaging in strenuous activities. Symptoms about 50% better at this time (friday). After visit with provider it was determined I may have had a similar reaction with my second Moderna shot but contributed it to stress or longhaul COVID (also had shortness of breath at that time- none with most current dose (booster)).
About 20 mins post injection, fever 100.Night of injection 103-104 early am 06/15/02 (Ibuprofen) felt "weak" rest of weekned. Okay today.
Patient with injection site reaction red swollen and warm next morning last 2 days and rash that comes and goes for 1 month.
Several days after getting my 2nd injection I developed a mild headache in my forehead. This went 2 weeks and then got worse as I  developed sinus/facial pain, brain fog, tiredness, chronic headaches, and migraine, tinnitus, vertigo, vision trouble including a cotton wool spot and insomnia, I have tried OTC medications for the headaches as well as a beta blocker and other prescriptions. Nothing has helped very much. and I am very frustrated. No doctors know what to do. I rarely had headaches before this vaccination.
About 5-7 minutes after the injection, I was sitting in the waiting area for my 15 minutes observation period. After about 5-7 minutes I noticed that it was hard for me to swallow and I became really flushed and hot and tachycardia. I was not anxious or upset about getting the shot. I am actually an ER physician and have had lots of shots in my life without any adverse reaction. The flushing and tachycardia resolved after about 20 minutes but the sensation of difficulty swallowing did not subside completely until I took  dose of Benadryl 50mg orally. Symptoms resolved after about 1 hour post Benadryl. I also had a recurrence of symptoms the next day at around 24 hours where I felt again like I couldn't swallow, so I took Benadryl 50mg again, but this time I also had some numbness of the left side of my tongue and the left side of my face.  The abnormal sensation in the left side of my face subsided over about an hour or so.
This spontaneous report as received from a pharmacist via a company representative refers to a female patient of unknown age with no medical history, drug reactions or allergies reported. On 06-APR-2015, the patient was vaccinated with ZOSTAVAX (route, dose and lot number were not reported) for shingles prevention. Concomitant medication was not reported. On approximately 07-APR-2015, the patient experienced itching, redness and swelling at injection site, so the patient contacted the pharmacy to seek medical attention and was prescribed BENADRYL. At the time of this report, the outcome of itching, redness and swelling at injection site was unknown. Additional information has been requested.
4 hours after pt got flu shot she got red itchy rash near injection site and it has since spread to both arms and chest and back and neck and flu shot was given on 10/22/13.
Hot at the injection site; Lump in my arm and big at Injection site; Itchy at the injection site; Erythema/Red at the injection; Swollen at the injection site; This spontaneous case was reported by an other health care professional and describes the occurrence of VACCINATION SITE WARMTH (Hot at the injection site), VACCINATION SITE MASS (Lump in my arm and big at Injection site), VACCINATION SITE PRURITUS (Itchy at the injection site), VACCINATION SITE ERYTHEMA (Erythema/Red at the injection) and VACCINATION SITE SWELLING (Swollen at the injection site) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Jan-2021, the patient experienced VACCINATION SITE WARMTH (Hot at the injection site), VACCINATION SITE MASS (Lump in my arm and big at Injection site), VACCINATION SITE PRURITUS (Itchy at the injection site), VACCINATION SITE ERYTHEMA (Erythema/Red at the injection) and VACCINATION SITE SWELLING (Swollen at the injection site). The patient was treated with FEXOFENADINE HYDROCHLORIDE (ALLEGRA) for Adverse event, at an unspecified dose and frequency and IBUPROFEN for Adverse event, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (Hot at the injection site), VACCINATION SITE MASS (Lump in my arm and big at Injection site), VACCINATION SITE PRURITUS (Itchy at the injection site), VACCINATION SITE ERYTHEMA (Erythema/Red at the injection) and VACCINATION SITE SWELLING (Swollen at the injection site) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Extraordinary headache, chest pains (strong but sporadic 3/4 of 1st day), bruising on inside of right leg 2nd morning.
EXPERIENCED IMMEDIATE CHEST TIGHTNESS, TACHYCARDIA, AND HYPERTENSION. BROUGHT TO ED FOR MONITORING AND SYMPTOMS RESOLVED.
On 9/12/11 about 5:30 pm received FLUZONE HD at 10pm patient states she woke with shakes because of chills and symptoms of freezing lasted about 20 minutes. She had tightness in her throat like she couldn't breathe. Arm hurt from shoulder to elbow. On 9/13/11 she woke up with headache, no appetite, very lethargic & fatigued. Slept all day. On 9/14/11 she feels like she has flu.
Body chills lasting from 7-9 pm the following day; Fatigue; Headache; Stomach pain; This is a spontaneous report from a contactable consumer, patient. A 37-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: EN6204), via an unspecified route of administration in the left arm on 14Mar2021 at 10:15 AM (at the age of 37-years-old) as single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccination. On 15Mar2021 at 7:00, the patient experienced body chills lasting from 7-9 pm the following day, headache, stomach pain and fatigue. Therapeutic measures were not taken for the events. The clinical outcome of body chills, headache, stomach pain and fatigue were recovered at the time of report.  No follow-up attempts are possible. No further information is expected.
w/in 24 hrs of immun pt lt arm was hot, red tender & swollen from shoulder to elbow; pt was afebrile;
Patient was given 12+ Bivalent Booster instead of 5-11 Bivalent Booster. Patient was not given an age appropriate vaccine. No treatment needed. Parents will be notified of even.
Fever, chills, red swollen hot arm at injection sight(about the size of a softball), muscle aches, tiredness
rapid and PCR came back positive (for Covid-19); This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (rapid and PCR came back positive (for Covid-19)) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014M20A and 040B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Mar-2021, the patient experienced COVID-19 (rapid and PCR came back positive (for Covid-19)). On 23-Mar-2021, COVID-19 (rapid and PCR came back positive (for Covid-19)) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Mar-2021, SARS-CoV-2 test: positive (Positive) COVID-19 rapid test. On 10-Mar-2021, SARS-CoV-2 test: positive (Positive) PCR COVID-19 test.         Patient had chills. It was reported that consumer was quarantined from 08 Mar 2021 until 23 Mar 2021. The symptoms have resolved but the consumer had not been retested for COVID-19.  No concomitant medication was reported  No treatment medication was reported   This case was linked to US-MODERNATX, INC.-MOD-2021-118325 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: Reporter details were updated. Second dose information updated.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-118325:Case for second dose
A physician reported the occurrence of injection site cellulitis in a child of unspecified age and gender who was vaccinated with diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (Infanrix) for prophylaxis. The vaccine provider submitted a report directly to VAERS. The pt's medical history, concurrent conditions and concurrent medications were not reported. On an unspecified date, the pt received an injection of Infanrix. At an unspecified time post-immunization, the pt experienced "pretty serious" limb swelling. The pt was seen at a "minor emergency" center. A diagnosis of injection site cellulitis was made and the physician prescribed an anti-inflammatory drug. The reporter considered the event to be probably related to Infanrix administration. As of 09/12/2002, the outcome of the event was unknown. Comment: This report has been linked to report A0380700A due to same reporter.